How Do Humans Get Parvo? Spread, Symptoms, Risk

Humans get parvovirus B19 mainly by breathing in respiratory droplets from an infected person, similar to how colds spread. This is a different virus from the one that infects dogs, and it spreads easily in schools, households, and workplaces, especially during late winter and early spring. By age 60, roughly 90% of adults have been infected at some point in their lives.

You Can’t Catch Parvo From Dogs

One of the most common reasons people search this question is concern about a sick pet. Canine parvovirus and human parvovirus B19 are related in name only. They are species-specific viruses, meaning the canine version cannot replicate in human cells and the human version cannot infect dogs. If your dog has parvo, the risk to you is zero. If you’re feeling sick after being around a dog with parvo, something else is causing your symptoms.

How Human Parvovirus Spreads

Parvovirus B19 travels from person to person through respiratory secretions. Coughing, sneezing, and even talking can release virus-containing droplets that someone nearby inhales. Close contact in crowded indoor settings is the most common scenario for transmission, which is why outbreaks tend to ripple through elementary schools and then into the households of the children who bring it home.

The virus can also spread through blood. This matters most in two situations: transfusions of blood products that weren’t screened for B19, and transmission from a pregnant person to the fetus through the placenta. Touching contaminated surfaces is a less significant route, but washing your hands frequently still reduces risk.

When You’re Actually Contagious

The tricky part of parvovirus B19 is that you’re most contagious before you know you’re sick. The virus sheds heavily during the first few days of mild, nonspecific symptoms like low-grade fever, headache, and fatigue. These early signs look identical to a common cold, so most people go about their normal routine and unknowingly expose others.

By the time the more recognizable symptoms appear, like a rash or joint pain, you are unlikely to still be contagious. It’s generally safe to return to work or school once the rash shows up. This backward timeline makes outbreaks difficult to contain, because by the time anyone realizes parvovirus is circulating, the most infectious window has already passed.

Symptoms in Children vs. Adults

In children, the hallmark sign is a bright red rash across both cheeks, often called the “slapped cheek” rash. It typically appears a few days after the initial fever and flu-like phase. A lacy, lighter rash may then spread to the trunk, arms, and legs. Most children recover without any treatment, and the illness is mild enough that many parents assume it was just a passing virus.

Adults tend to have a different experience. The facial rash is less common, and instead the dominant symptom is joint pain and swelling, particularly in the hands, feet, and knees. It usually affects joints symmetrically on both sides of the body and is more common in women. The joint pain typically lasts one to three weeks, though in some cases it lingers for months. Some adults experience joint pain as their only symptom and never develop a rash at all, which means many infections go undiagnosed.

Who Faces Serious Risk

For most healthy people, parvovirus B19 is a nuisance, not a danger. But certain groups face real complications.

People with chronic blood disorders like sickle cell disease are especially vulnerable. The virus specifically targets and damages immature red blood cells in the bone marrow, temporarily shutting down red blood cell production. In someone whose red blood cells already break down faster than normal, this can trigger a transient aplastic crisis, a sudden and severe drop in red blood cells that may require hospitalization and blood transfusions.

People with weakened immune systems, whether from chemotherapy, organ transplants, or conditions like HIV, can develop a prolonged infection because their body can’t clear the virus efficiently. Instead of a short-lived illness, they may experience chronic anemia that persists until their immune function improves.

Pregnancy carries its own set of concerns. If a pregnant person contracts B19 for the first time during pregnancy, the virus can cross the placenta and infect the fetus. A systematic review and meta-analysis found that roughly 9.3% of infected pregnant women develop fetal hydrops, a condition where abnormal fluid accumulates in the fetus’s tissues due to severe anemia. The risk is highest during the first half of pregnancy. Most infected pregnancies still result in healthy births, but monitoring with ultrasound is important if exposure is confirmed.

How Common Is It?

Parvovirus B19 is far more widespread than most people realize. About 5 to 10% of young children between ages 2 and 5 already carry antibodies from a past infection. That number climbs to 50% by age 15 and 60% by age 30. A small percentage of adults catch it each year, pushing seroprevalence to around 90% among people over 60. Once you’ve been infected, you develop lifelong immunity and won’t get it again.

This means that many adults who worry about exposure have likely already had the virus at some point in childhood without ever realizing it. A blood test can determine your immunity status. A positive result for long-term antibodies (IgG) with negative short-term antibodies (IgM) means you were infected in the past and are now immune. If both markers are negative, you’ve never been infected and remain susceptible.

Prevention Without a Vaccine

There is no vaccine for parvovirus B19. Prevention comes down to basic hygiene: washing hands thoroughly with soap and water, covering coughs and sneezes, and avoiding sharing utensils or drinks. These measures help, but they can’t fully prevent spread because the most contagious window happens before anyone knows the virus is present.

During known outbreaks in schools or workplaces, pregnant individuals and people with blood disorders or compromised immune systems should be aware of their exposure risk. If you fall into one of these groups and know you’ve been exposed, a blood test can clarify whether you’re already immune or whether monitoring is warranted.